scholarly article | Q13442814 |
P50 | author | Anisha A. Gupte | Q39829946 |
Keith A Youker | Q51717527 | ||
Dale J. Hamilton | Q61785100 | ||
Guillermo Torre-Amione | Q99344173 | ||
Matthias Loebe | Q114312358 | ||
P2093 | author name string | Willa A Hsueh | |
Heinrich Taegtmeyer | |||
Andrea M Cordero-Reyes | |||
P2860 | cites work | Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart | Q28570211 |
The failing heart--an engine out of fuel | Q29617881 | ||
Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart | Q33566045 | ||
Defective DNA replication impairs mitochondrial biogenesis in human failing hearts | Q33892073 | ||
Biochemical studies of energy production in the failing human heart | Q34080123 | ||
Interaction of TNF with angiotensin II contributes to mitochondrial oxidative stress and cardiac damage in rats | Q34441654 | ||
Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease | Q35556097 | ||
Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation | Q36870637 | ||
Mitochondria in cardiac hypertrophy and heart failure | Q37246892 | ||
Modulation of mitochondrial bioenergetics in the isolated Guinea pig beating heart by potassium and lidocaine cardioplegia: implications for cardioprotection. | Q37415419 | ||
Mitochondria in the human heart | Q37437393 | ||
Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity | Q38319554 | ||
Abnormal biochemistry in myocardial failure | Q39898667 | ||
Quantification of the contribution of various steps to the control of mitochondrial respiration. | Q41619983 | ||
Transgenic mouse model with deficient mitochondrial polymerase exhibits reduced state IV respiration and enhanced cardiac fibrosis | Q41940970 | ||
Abnormal mitochondrial respiration in failed human myocardium | Q42497033 | ||
Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload | Q43207763 | ||
Metabolic gene expression in fetal and failing human heart | Q43819742 | ||
Energy status of the rapidly paced canine myocardium in congestive heart failure | Q43841823 | ||
Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy | Q44203656 | ||
Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression | Q44264771 | ||
Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy | Q44693079 | ||
Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure | Q44842105 | ||
Mitochondrial tissue specificity of substrates utilization in rat cardiac and skeletal muscles. | Q45134661 | ||
Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes | Q46098709 | ||
Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats | Q46532282 | ||
Pressure overload differentially affects respiratory capacity in interfibrillar and subsarcolemmal mitochondria | Q48559552 | ||
Differential changes in respiratory capacity and ischemia tolerance of isolated mitochondria from atrophied and hypertrophied hearts. | Q54592330 | ||
Respiratory enzymes in oxidative phosphorylation. III. The steady state. | Q55037006 | ||
Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy | Q57631631 | ||
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu | Q58975447 | ||
Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts | Q60056610 | ||
Decreased mitochondrial oxidative phosphorylation capacity in the human heart with left ventricular systolic dysfunction | Q61918740 | ||
Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle | Q67715072 | ||
Some biochemical studies on subcellular systems isolated from fresh recipient human cardiac tissue obtained during transplantation | Q68467960 | ||
Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy | Q73622527 | ||
Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria | Q73757751 | ||
Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure | Q77072342 | ||
Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy | Q77829273 | ||
2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Deve | Q83631957 | ||
Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart | Q84838077 | ||
Research advances in heart failure: a compendium | Q87150620 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | mitochondrion | Q39572 |
P304 | page(s) | 98-105 | |
P577 | publication date | 2014-01-09 | |
P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
P1476 | title | Freshly isolated mitochondria from failing human hearts exhibit preserved respiratory function | |
P478 | volume | 68 |
Q35235782 | A PKM2 signature in the failing heart. |
Q40679405 | Assessment of Mitochondrial Dysfunction and Monoamine Oxidase Contribution to Oxidative Stress in Human Diabetic Hearts |
Q52575994 | Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond. |
Q49022015 | Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure |
Q90349841 | Effective Metabolic Approaches for the Energy Starved Failing Heart: Bioenergetic Resiliency via Redundancy or Something Else? |
Q37263909 | Estrogen receptor alpha activation enhances mitochondrial function and systemic metabolism in high-fat-fed ovariectomized mice. |
Q33651722 | Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning |
Q47381689 | Heart failure-induced activation of phospholipase iPLA2γ generates hydroxyeicosatetraenoic acids opening the mitochondrial permeability transition pore |
Q64244369 | High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure |
Q38974621 | How cardiomyocytes sense pathophysiological stresses for cardiac remodeling. |
Q51531441 | Hypertrophy induced KIF5B controls mitochondrial localization and function in neonatal rat cardiomyocytes. |
Q51763166 | Improved Cardiovascular Function in Old Mice after N-Acetyl Cysteine and Glycine Supplemented Diet: Inflammation and Mitochondrial Factors. |
Q54210821 | Inducible Lung Epithelial Resistance Requires Multisource Reactive Oxygen Species Generation To Protect against Viral Infections. |
Q89180768 | Metabolic Coordination of Physiological and Pathological Cardiac Remodeling |
Q39245449 | Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options. |
Q27312512 | Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: integrated metabolomics and proteomics study |
Q39395331 | Metabolic remodelling in hypertrophied and failing myocardium: a review. |
Q39334518 | Mitochondrial Bioenergetics and Dysfunction in Failing Heart |
Q88169588 | Mitochondrial Function in Non-ischemic Heart Failure |
Q38759545 | Mitochondrial Therapies in Heart Failure |
Q42053286 | Mitochondrial structure and function are not different between nonfailing donor and end-stage failing human hearts |
Q28395925 | Monoamine Oxidases as Potential Contributors to Oxidative Stress in Diabetes: Time for a Study in Patients Undergoing Heart Surgery |
Q38864091 | Myocardial recovery with mechanical circulatory support |
Q37743798 | Pet Imaging and its Application in Cardiovascular Diseases |
Q52624291 | Polymer Functionalization of Isolated Mitochondria for Cellular Transplantation and Metabolic Phenotype Alteration. |
Q28387956 | Probing cytochrome c in living mitochondria with surface-enhanced Raman spectroscopy |
Q38265521 | Rethinking cardiac metabolism: metabolic cycles to refuel and rebuild the failing heart |
Q37139657 | Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation. |
Q54481620 | Simultaneous exposure to nitric oxide inhibition and angiotensin II overload: is it a murine model of mitochondrial dysfunction in nonischemic heart failure? |
Search more.